These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efforts at making the diagnosis of acute-onset autoimmune hepatitis. Fujiwara K; Yasui S; Yokosuka O Hepatology; 2011 Jul; 54(1):371-2; author reply 373. PubMed ID: 21452289 [No Abstract] [Full Text] [Related]
6. [Autoimmune hepatitis often requires lifelong treatment]. Werner M; Danielsson A Lakartidningen; 2010 May 26-Jun 1; 107(21):1388-91. PubMed ID: 20645615 [No Abstract] [Full Text] [Related]
7. Variant forms of autoimmune hepatitis. Czaja AJ Curr Gastroenterol Rep; 1999; 1(1):63-70. PubMed ID: 10980929 [TBL] [Abstract][Full Text] [Related]
11. Case of the month. Grade I hepatic encephalopathy. Trant H JAAPA; 2011 Jun; 24(6):70. PubMed ID: 21682182 [No Abstract] [Full Text] [Related]
12. Acute viral E hepatitis with chronic liver disease (autoimmune hepatitis). Desai HG; Naik AS Indian J Med Sci; 2005 Mar; 59(3):113-5. PubMed ID: 15805682 [TBL] [Abstract][Full Text] [Related]
13. Late relapse of type 1 autoimmune hepatitis after corticosteroid withdrawal. Czaja AJ Dig Dis Sci; 2010 Jun; 55(6):1761-9. PubMed ID: 20428945 [TBL] [Abstract][Full Text] [Related]
14. Early Dynamics of MELD Scores Predict Corticosteroid Responsiveness to Severe Acute-Onset Autoimmune Hepatitis. Noguchi F; Chu PS; Yoshida A; Taniki N; Morikawa R; Hasegawa Y; Yamataka K; Hoshi H; Kasuga R; Tabuchi T; Ebinuma H; Shinoda M; Obara H; Kitagawa Y; Kanai T; Nakamoto N Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2641-2643.e3. PubMed ID: 34102339 [TBL] [Abstract][Full Text] [Related]
15. Challenges in the use of corticosteroids in the management of autoimmune hepatitis. Chapman RW; Aspinall RJ; Trivedi P; Wright G; Heneghan M Br J Hosp Med (Lond); 2019 Oct; 80(10):594-599. PubMed ID: 31589514 [TBL] [Abstract][Full Text] [Related]
16. Unmet needs and new models for future trials in autoimmune hepatitis. Jones D; Manns MP; Terracciano L; Torbenson M; Vierling JM Lancet Gastroenterol Hepatol; 2018 May; 3(5):363-370. PubMed ID: 29644978 [TBL] [Abstract][Full Text] [Related]
17. Features and consequences of untreated type 1 autoimmune hepatitis. Czaja AJ Liver Int; 2009 Jul; 29(6):816-23. PubMed ID: 19018980 [TBL] [Abstract][Full Text] [Related]
18. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Czaja AJ; Menon KV; Carpenter HA Hepatology; 2002 Apr; 35(4):890-7. PubMed ID: 11915036 [TBL] [Abstract][Full Text] [Related]
20. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Montano-Loza AJ; Carpenter HA; Czaja AJ Hepatology; 2007 Oct; 46(4):1138-45. PubMed ID: 17668882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]